Pharmaceutical
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-PSUSA-00010912-202206: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Advanced pharmaceutical formulation for targeted therapeutic intervention.